Comparison of holmium laser turbinate reduction and partial turbinoplasty in the surgical treatment of rhinitis medicamentosa
- 2 June 2026
- journal article
- research article
- Published by Cambridge University Press (CUP) in The Journal of Laryngology & Otology
- Vol. 140 (7) , 1-5
Abstract
Objectives: Rhinitis medicamentosa is a challenging condition resulting from prolonged nasal decongestant use. This study aimed to compare holmium laser turbinate reduction and partial turbinoplasty surgical options. Methods: A retrospective cohort study was conducted, including 65 patients diagnosed with rhinitis medicamentosa, with a minimum post-operative follow up of 12 months. Symptom severity and quality of life were assessed pre- and post-operatively using the Sino-Nasal Outcome Test 22 (SNOT-22) and the visual analogue scale (VAS). Results: Both surgical techniques resulted in significant post-operative improvement in SNOT-22 and VAS scores. Post-operative SNOT-22 total and obstruction scores were significantly lower in the partial turbinoplasty group compared with the holmium laser turbinate reduction group ( p < 0.05). Post-operative VAS scores did not differ significantly between groups ( p > 0.05). The partial turbinoplasty group demonstrated higher incidence of early post-operative complications. Conclusion: Both holmium laser turbinate reduction and partial turbinoplasty are effective surgical options for rhinitis medicamentosa. Surgical technique selection should be individualised based on disease severity, patient expectations and risk tolerance.Keywords
This publication has 20 references indexed in Scilit:
- Platelet‐Rich Plasma for Rhinitis Medicamentosa: A Promising Histopathological Study in an Animal ModelOtolaryngology–Head and Neck Surgery, 2025
- Variants of rhinitis medicamentosa treatment: a systematic reviewEuropean Archives of Oto-Rhino-Laryngology, 2025
- Outcomes after Functional Nasal Surgery in Patients with Versus without Rhinitis MedicamentosaThe Laryngoscope, 2024
- Long‐term treatment outcomes in refractory rhinitis medicamentosa managed with nasal surgeryInternational Forum of Allergy & Rhinology, 2023
- Quality of life after radio frequency ablation turbinate reduction (RFATR) among patients with rhinitis medicamentosa & withdrawal from decongestant topical spray abuseAmerican Journal of Otolaryngology, 2023
- Xylitol treats nasal mucosa in rhinitis medicamentosa: an experimental rat model studyEuropean Archives of Oto-Rhino-Laryngology, 2019
- Long‐term outcomes in medial flap inferior turbinoplasty are superior to submucosal electrocautery and submucosal powered turbinate reductionInternational Forum of Allergy & Rhinology, 2015
- Rhinitis medicamentosa: what an otolaryngologist needs to knowEuropean Archives of Oto-Rhino-Laryngology, 2008
- Rhinitis medicamentosa: Electron microscopic changes of human nasal mucosaOtolaryngology–Head and Neck Surgery, 2007
- Laser treatment of hyperplastic inferior nasal turbinates: A reviewLasers in Surgery and Medicine, 2001